| Ibalizumab, a novel monoclonal antibody for the management of multidrug-resistant HIV-1 infection MV Beccari, BT Mogle, EF Sidman, KA Mastro, E Asiago-Reddy, WD Kufel Antimicrobial agents and chemotherapy 63 (6), 10.1128/aac. 00110-19, 2019 | 92 | 2019 |
| Clinical review of delafloxacin: a novel anionic fluoroquinolone BT Mogle, JM Steele, SJ Thomas, KBH Bohan, WD Kufel Journal of Antimicrobial Chemotherapy 73 (6), 1439-1451, 2018 | 68 | 2018 |
| Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia BT Mogle, JM Steele, RW Seabury, UJ Dang, WD Kufel International journal of antimicrobial agents 52 (6), 805-810, 2018 | 60 | 2018 |
| Readiness to implement vancomycin monitoring based on area under the concentration–time curve: a cross-sectional survey of a national health consortium WD Kufel, RW Seabury, BT Mogle, MV Beccari, LA Probst, JM Steele American Journal of Health-System Pharmacy 76 (12), 889-894, 2019 | 54 | 2019 |
| Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. JM Steele, RW Seabury, CM Hale, BT Mogle Journal of Clinical Pharmacy & Therapeutics 43 (1), 2018 | 44 | 2018 |
| Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections BT Mogle, MV Beccari, JM Steele, T Fazili, WD Kufel Expert Opinion on Pharmacotherapy 20 (8), 903-907, 2019 | 27 | 2019 |
| In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis WD Kufel, AP Eranki, KM Paolino, A Call, CD Miller, BT Mogle Journal of Antimicrobial Chemotherapy 74 (7), 2117-2118, 2019 | 21 | 2019 |
| Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban AE Woodruff, MM Wovkulich, BT Mogle, AK Hassan American Journal of Health-System Pharmacy 75 (22), 1783-1789, 2018 | 14 | 2018 |
| A single-center cost analysis assessing a change in vasopressin formulation CE Kelly, C Miller, W Darko, G Cwikla, B Mogle, J Featherly, R Marcinak, ... American Journal of Health-System Pharmacy 78 (13), 1238-1243, 2021 | 4 | 2021 |
| Severe neutrophilic dermatosis following submental deoxycholic acid administration BT Mogle, RW Seabury, S Jennings, GM Cwikla Clinical Toxicology 55 (7), 681-681, 2017 | 4 | 2017 |
| Cost comparison of AUC: MIC–versus trough-based vancomycin monitoring for MRSA bacteremia MV Beccari, RW Seabury, BT Mogle, WD Kufel, CD Miller, JM Steele Journal of the American Pharmacists Association 60 (5), 729-733, 2020 | 3 | 2020 |
| The culture of carbapenem overconsumption: where does it begin? Results of a single-center survey BT Mogle, RW Seabury, Z Jones, CD Miller, JM Steele Hospital Pharmacy 54 (3), 175-179, 2019 | 2 | 2019 |
| Comparison of vancomycin area under the concentration‐time curve (AUC) using two‐point pharmacokinetics versus two open‐access online single‐concentration vancomycin calculators NM Ondrush, R Ademovic, RW Seabury, W Darko, CD Miller, BT Mogle Journal of Clinical Pharmacy and Therapeutics 47 (12), 2223-2229, 2022 | 1 | 2022 |
| Providers' knowledge and perceptions regarding antibiotic stewardship and antibiotic prescribing in rural primary care clinics WD Kufel, KA Mastro, BT Mogle, KS Williams, J Jester, J Snyder, ... Journal of the American College of Clinical Pharmacy 3 (3), 601-608, 2020 | | 2020 |
| 1303. Provider Knowledge and Attitudes Toward Antibiotic Prescribing and Antibiotic Stewardship in Outpatient Rural Clinics W Kufel, B Mogle, K Williams, J Jester, J Snyder, K Mastro, T Lubowski, ... Open Forum Infectious Diseases 5 (Suppl 1), S398, 2018 | | 2018 |
| Therapeutic drug monitoring for vancomycin: past, present and future NM Ondrush, BT Mogle | | |
